U.S. specialty biopharmas SteadyMed and United Therapeutics both issued media releases recently commenting on a ruling by the…
Articles by Charles Moore
Paris-based biotechnology company Mifcare is getting support from the French pulmonary hypertension patients’ association HTaPFrance for the development of new anti-inflammatory…
SteadyMed Therapeutics, a California-based specialty pharmaceutical company that develops drug products for treating orphan and high-value diseases with…
November is Pulmonary Hypertension Awareness Month and, in recognition, SteadyMed has announced the launch of its new website,…
Serena Lawrence, a young Canadian living with pulmonary hypertension (PH), has launched an online petition to raise public…
Erica Huntzinger, today a pulmonary hypertension (PH) activist and advocate, remembers her mother, Susan, beginning to experience PH symptoms in her…
Reata Pharmaceuticals, Inc., recently announced in a press release the pricing of its initial public offering of 5,500,000 shares…
The Pulmonary Hypertension Association of Canada will join more than 80 other organizations worldwide to mark World…
On May 5, more than 80 organizations around the world will participate in activities designed to raise awareness of this…
Haifa, Israel-based Pluristem Therapeutics Inc. announced that it has received a notice from United Therapeutics Corporation ending its licensing…
Residents of the Canadian province of Ontario affected by pulmonary arterial hypertension (PAH) gathered at the Queen’s Park provincial…
A new survey sponsored by Bayer has revealed that many physicians report a lack of familiarity with a condition called…